Home / Resources / Articles / Study Sheds Light On How Oxygen Effects Birth Defects In Diabetic Pregnancy

Study Sheds Light On How Oxygen Effects Birth Defects In Diabetic Pregnancy

Oct 11, 2005
1,397 views
 

The babies of women with diabetes are two to five times more likely to develop birth defects than offspring of women without diabetes. Study suggests that high blood glucose levels early in pregnancy deprive the embryo of oxygen, interfering with its development.

More reasons why it is necessary to have normal blood sugars even before getting pregnant and during the first 8 weeks of pregnancy.

 

A cascade of events that begins with high blood glucose has been offered as an explanation for why diabetic pregnancies result in a high rate of birth defects. The high blood glucose levels early in pregnancy deprive the embryo of oxygen, leading to high levels of free radicals that reduce expression of a key gene called Pax3, said Mary R. Loeken, Ph.D., of Harvard Medical School.

In a study researchers performed a series of experiments on pregnant mice with induced diabetes. They explored the role of the Pax3 gene, which is required for forming a healthy brain and spinal cord, and has been implicated by previous research in birth defects in diabetic pregnancies. Human diabetic pregnancies are two to five times more likely to result in birth defects.

The researchers measured oxygen concentrations in the embryos of these mice, analyzed Pax3 expression, measured markers of oxidative stress, and examined embryos for neural tube defects. They also measured the effects of reduced oxygen supply and increased oxygen supply on embryonic development.

Compared with healthy controls, oxygen concentrations in the embryos of diabetic mice were reduced by 30% (P<.005). The researchers believed that because the embryos had to break down higher levels of glucose, they used up oxygen faster than it could be delivered.

Furthermore, both pregnant mice with diabetes and those housed in a low (12%) oxygen environment showed a fivefold decrease in Pax3 expression and an eightfold increase in neural tube defects compared with controls (P<.001). Conversely, a high-oxygen (30%) environment blocked these effects in pregnant diabetic mice.

Both oxygen-restricted and diabetic pregnant mice showed increased levels of markers of oxidative stress compared with healthy controls (P<.001). But in mice who received high supplementation of the antioxidant vitamin E, oxidative stress was reduced and decreased Pax3 expression and neural tube defects were prevented. The exact mechanism by which oxidative stress leads to inhibition of Pax3 expression is unknown.

These results have clinical implications both for women with diabetes and women who are obese who intend to become pregnant, Dr. Loeken said.

“Women with diabetes should be consulting with their healthcare team to be sure they have good glycemic control before becoming pregnant,” she added. Maintaining blood glucose control continues to be important throughout the pregnancy, she said, but it is particularly important during the first eight weeks, when an embryo’s organs are forming.

Li R et al. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. American Journal of Physiology: Endocrinology and Metabolism. 2005; 289:E591-E599.

================================

DID YOU KNOW:
Blood pressure control using a single agent only adequately controls blood pressure in about one half of mildly hypertensive patients. In 1997, it was reported that awareness, treatment, and control of hypertension was no longer improving compared with previous decades. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) now recommends most hypertensive patients will require two or more antihypertensive medications to achieve their blood pressure goals. Numerous reports suggest that combination therapy possesses many inherent advantages over monotherapy. These benefits may include better response rates, fewer dose-dependent side effects, and improved efficacy.